human adipose derived mesenchymal progenitor cell therapy
/ AbelZeta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 22, 2024
A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection
(clinicaltrials.gov)
- P1/2 | N=60 | Suspended | Sponsor: Ruijin Hospital | Trial completion date: Jul 2023 ➔ Mar 2025 | Recruiting ➔ Suspended | Trial primary completion date: May 2023 ➔ Dec 2024
Gram negative • Trial completion date • Trial primary completion date • Trial suspension • Infectious Disease • Respiratory Diseases
September 10, 2020
A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection
(clinicaltrials.gov)
- P1/2; N=60; Recruiting; Sponsor: Ruijin Hospital
Clinical • New P1/2 trial
1 to 2
Of
2
Go to page
1